Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-031595
Filing Date
2021-12-15
Accepted
2021-12-15 16:52:44
Documents
67
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 771383
2 ex31-1.htm EX-31.1 17771
3 ex31-2.htm EX-31.2 18469
4 ex32-1.htm EX-32.1 7071
5 ex32-2.htm EX-32.2 7594
  Complete submission text file 0001493152-21-031595.txt   4457523

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oncs-20211031.xsd EX-101.SCH 37813
7 XBRL CALCULATION FILE oncs-20211031_cal.xml EX-101.CAL 58279
8 XBRL DEFINITION FILE oncs-20211031_def.xml EX-101.DEF 145162
9 XBRL LABEL FILE oncs-20211031_lab.xml EX-101.LAB 340710
10 XBRL PRESENTATION FILE oncs-20211031_pre.xml EX-101.PRE 267064
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 596125
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Filer) CIK: 0001444307 (see all company filings)

EIN.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-54318 | Film No.: 211494794
SIC: 2834 Pharmaceutical Preparations